ClinicalTrials.gg
RecruitingNCT07446985Updated Mar 3, 2026

Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?

An interventional study of exercise plus limiitng diet and limiting diet in Polycystic Ovary Syndrome and Asthma, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to female participants aged 20 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-03-03.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 30 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Polycystic Ovary Syndrome by Cairo University — 10 open to participants now, 10 under way, none of them phase 3. Polycystic Ovary Syndrome · Cairo University.

Planned enrollment
17th of 26
40 · median 55
Started
2026
with 3 others
No phase
20 of 34
10 open now
Registered
31st of 34
by date

Among the 34 studies in Polycystic Ovary Syndrome by Cairo University, this one is the 17th largest by planned enrollment of the 26 interventional ones that give a count, is one of 4 that started in 2026, is one of 20 with no phase, and was the 31st registered.

Polycystic Ovary Syndrome

959 studies on the registry are indexed under Polycystic Ovary Syndrome; 176 are open to participants now.

Browse Polycystic Ovary Syndrome studies →

Open to participants now

10 of the 34 studies in Polycystic Ovary Syndrome by Cairo University are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 120 Polycystic Ovary Syndrome studies recruiting now, 11 (9%) set no upper age limit and 106 (88%) stop at 75 or younger; 23 take children under 18; 41 take healthy volunteers.

This study: 20 Years to 30 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Polycystic Ovary Syndrome by Cairo University, or all of them as a file.
02

Study summary

Women with polysyctic ovarian syndrome (PCOS) usually develop many complications including asthma. Nowdays, diet restriction combimed with phsyical exercises may improve both problems

Read the detailed description

Forty Women with asthma with PCOS will be enrolled to be catogrized to Group I or group II. Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks. Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks

03

Conditions studied

  • Polycystic Ovary Syndrome
  • Asthma
04

Who can participate

Ages eligible
20 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • PCOS women
  • women with asthma
  • obese women (calss I)

Exclusion criteria

Exclusion Criteria:

  • cardiac problems
  • renal problems
  • liver problems
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    group number 1

    Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks.

    Behavioral: exercise plus limiitng diet

  • Active comparator
    group number 2

    Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks

    Behavioral: limiting diet

Interventions

  • Behavioralexercise plus limiitng diet

    Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks.

  • Behaviorallimiting diet

    Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks

06

What researchers measure

Primary outcomes

  1. forced vital capcity

    it is a pulmonary function testing

    Time frame: it will be measured after 12 weeks

Secondary outcomes

  1. forced expiratory volume

    it is a pulmonary function testing at the first second of expiration

    Time frame: It will be measured after 12 weeks

  2. forced expiratory volume to forced expiratory capcity

    it is a common ratio test in pulmonary function examiantions

    Time frame: It will be measured after 12 weeks

  3. body mass index

    it will be assessed on empty stomach and bladder

    Time frame: It will be measured after 12 weeks

  4. waist circumference

    it will be assessed at level of patient umblicus

    Time frame: it will be measured after 12 weeks

  5. waist hip ratio

    it is a measure of excess weight

    Time frame: It will be measured after 12 weeks

  6. Mini asthma quality of life questionnaire

    it is a questioanire assessing life quality in asthma

    Time frame: It will be measured after 12 weeks

  7. scale of fatigue severity

    it is a questionaire assesing fatigue

    Time frame: It will be measured after 12 weeks

  8. luteinizing-hormone to follicle-stimulating-hormone ratio

    it is an indicator on level of sex hormone production

    Time frame: It will be measured after 12 weeks

  9. Testosterone

    it is androgen hormone

    Time frame: It will be measured after 12 weeks

  10. Dehydroepiandrosterone

    it is a hormone that body naturally produces in the adrenal gland

    Time frame: It will be measured after 12 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Jun 2026, 4 months after the start.

Of 205 non-industry interventional studies with no phase under Polycystic Ovary Syndrome, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 4 months is below that.

Counting every sponsor, half of 220 studies reached it within 17 months; a quarter within 7 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2026
First posted
Mar 3, 2026
StartActual
Feb 7, 2026
Primary completionEst.
Jun 30, 2026
CompletionEst.
Jul 15, 2026
Last update
Mar 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07446985
Lead sponsor
Cairo University
Responsible party
Ali Mohamed Ali ismail (lecturer of physical therapy for Cardiovascular, Respiratory disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Cairo University) — Principal investigator
First posted
Mar 3, 2026
Start date
Feb 7, 2026
Primary completion
Jun 30, 2026 (estimated)
Completion
Jul 15, 2026 (estimated)
Last update
Mar 3, 2026

Study contacts

Ali MA Ismail, lecturer
Contact
ali.mohamed@pt.cu.edu.eg
01005154209
ali mohamed
Contact
fatmaraed1994@gmail.com
0201031321109
Ali MA Ismail, lecturer
principal investigator · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion